- CRISPR-edited cell lines targeting key molecular pathways
- A novel approach for antibody affinity maturation using AI-driven mutation prediction
- MPSA-AB5000: A high-throughput membrane protein screening array for therapeutic biologics specificity profiling
- Over 200! The largest BaF3-EGFR engineered cell line collection A versatile platform for novel drug discovery
- FGFR cell lines: A comprehensive approach to drug discovery and evaluation, from small molecules to biologics
- Improved Ba/F3 kinase engineered cell lines :An innovative in vivo screening platform
- LgBiT-HiBiT engineered cell lines for protein degradation detection:Comprehensive PROTAC evaluation platform with endpoint and real-time kinetic analysis
- MegaScreen,A robust platform for ADC drug evaluation
- In vitro and in vivo screening platform for discovery of JAK2 inhibitor
- KA-3123-LD38:A novel bispecific ADC targeting EGFR and B7H3 with a DNA topoisomerase I inhibitor payload
- KA-2887-LD38:A bispecific ADC targeting both EGFR and PD-L1
- KA-2886-LD38:A bispecific ADC targeting both EGFR and MET, incorporating a novel linker-payload that inhibits DNA topoisomerase I